COVID-19 vaccine boosters could mean billions for drugmakers
By The Associated Press - | Sep 26, 2021
FILE - In this March 2021 photo provided by Pfizer, a technician works on a line for packaging preparation for the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium. Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans' protection against the virus. (Pfizer via AP)
SIGN UP TO CONTINUE
Print Subscriber? Sign Up for Full Access!
Please sign up for as low as 36 cents per day to continue viewing our website.
Digital subscribers receive
Unlimited access to all stories from nashuatelegraph.com on your computer, tablet or smart phone.
Access nashuatelegraph.com, view our digital edition or use our Full Access apps.
Get more information at nashuatelegraph.com/fullaccess